Expertise · Clinical & Preclinical Studies

Can My Drug Use a BCS Biowaiver Instead of an EAEU Bioequivalence Study?

Development programmes supporting medicinal product registration

This section brings together clinical, bioequivalence and preclinical evidence used to support medicinal product registration, including local-study strategy, foreign-data usability, GCP/GLP inspection risk, biowaivers and biological products.

Detailed guidance across the evidence programme is available in the current technical library.

Clinical and preclinical evidence strategy supporting EAEU registration
Loading…